Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Breast Cancer peptide evidence brief
A cited Breast Cancer peptide evidence brief across 26 exact-label ClinicalTrials.gov records, 7 connected profiles, and 14 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
26 selected records.
7 profiles.
2012–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Breast Cancer?
PeptideScanner’s selected collection contains 26 retained ClinicalTrials.gov records carrying the exact condition label “Breast Cancer,” connected to 7 peptide profiles across 14 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Breast Cancer, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 268 selected PubMed records and 72 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Breast Cancer unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Breast Cancer.
Goserelin · source record 2026-08-13
Roles of Goserelin in Gynecological Disorders.
PubMed lists PMID 42226753 in Drug design, development and therapy as Journal Article, Review, with publication-date metadata of 2026-05-27 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Triptorelin · source record 2026-11-09
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
PubMed lists PMID 25990480 in Archives of gynecology and obstetrics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2015-05-20 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Leuprolide · source record 2026-11-06
Leuprolide acetate, a GnRH agonist, preserves cerebellar integrity and motor coordination in a rat model of hepatic encephalopathy.
PubMed lists PMID 42962871 in Physiology & behavior as Journal Article, with publication-date metadata of 2026-10-30 (day precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Desmopressin · source record 2026-10-29
Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing's syndrome: A systematic review and meta-analysis.
PubMed lists PMID 35478451 in Reviews in endocrine & metabolic disorders as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2022-04-28 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Pasireotide · source record 2026-10-31
Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas.
PubMed lists PMID 42778805 in Pituitary as Journal Article, with publication-date metadata of 2026-09-23 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Thymosin alpha-1 · source record 2026-09-29
Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.
PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01606072
PeptideScanner retained ClinicalTrials.gov record NCT01606072 at 2026-11-16T01:33:21.554Z. Its registry update date was 2015-08-28, and PeptideScanner's reviewed identity mapping was desmopressin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- August 28, 2015
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00066703
PeptideScanner retained ClinicalTrials.gov record NCT00066703 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was triptorelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- February 6, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00186121
PeptideScanner retained ClinicalTrials.gov record NCT00186121 at 2026-11-15T21:50:32.222Z. Its registry update date was 2019-10-07, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 7, 2019
- Evidence lane
- Clinical trials
Exact-record source chronology
Breast Cancer registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
8 recordsLeuprolide · 2026-10-23
ClinicalTrials.gov record NCT01674140
Active, not recruiting at the retained observation.
Open cited registry record →Thymosin alpha-1 · 2026-10-20
ClinicalTrials.gov record NCT07884201
Not yet recruiting at the retained observation.
Open cited registry record →Leuprolide · 2026-08-24
ClinicalTrials.gov record NCT07596212
Not yet recruiting at the retained observation.
Open cited registry record →Tirzepatide · 2026-07-22
ClinicalTrials.gov record NCT07257484
Recruiting at the retained observation.
Open cited registry record →Goserelin · 2026-07-08
ClinicalTrials.gov record NCT03671330
Completed at the retained observation.
Open cited registry record →Triptorelin · 2026-04-24
ClinicalTrials.gov record NCT05982093
Recruiting at the retained observation.
Open cited registry record →Triptorelin · 2026-02-24
ClinicalTrials.gov record NCT05896566
Completed at the retained observation.
Open cited registry record →Triptorelin · 2026-02-06
ClinicalTrials.gov record NCT00066703
Completed at the retained observation.
Open cited registry record →2025
1 recordGoserelin · 2025-10-16
ClinicalTrials.gov record NCT03822468
Completed at the retained observation.
Open cited registry record →2024
3 recordsGoserelin · 2024-10-09
ClinicalTrials.gov record NCT03839823
Completed at the retained observation.
Open cited registry record →Goserelin · 2024-03-20
ClinicalTrials.gov record NCT03007979
Completed at the retained observation.
Open cited registry record →Goserelin · 2024-03-15
ClinicalTrials.gov record NCT00295646
Completed at the retained observation.
Open cited registry record →2023
1 recordGoserelin · 2023-04-03
ClinicalTrials.gov record NCT00432172
Completed at the retained observation.
Open cited registry record →2022
1 recordGoserelin · 2022-01-21
ClinicalTrials.gov record NCT02586675
Completed at the retained observation.
Open cited registry record →2021
1 recordGoserelin · 2021-06-11
ClinicalTrials.gov record NCT02518191
Completed at the retained observation.
Open cited registry record →2020
1 recordTriptorelin · 2020-12-09
ClinicalTrials.gov record NCT04659551
Completed at the retained observation.
Open cited registry record →2019
1 recordGoserelin · 2019-10-07
ClinicalTrials.gov record NCT00186121
Completed at the retained observation.
Open cited registry record →2018
1 recordGoserelin · 2018-12-12
ClinicalTrials.gov record NCT01073865
Completed at the retained observation.
Open cited registry record →2017
1 recordPasireotide · 2017-01-25
ClinicalTrials.gov record NCT01356862
Completed at the retained observation.
Open cited registry record →2016
2 recordsTriptorelin · 2016-07-25
ClinicalTrials.gov record NCT00659373
Completed at the retained observation.
Open cited registry record →Leuprolide · 2016-04-18
ClinicalTrials.gov record NCT00903162
Completed at the retained observation.
Open cited registry record →2015
1 recordDesmopressin · 2015-08-28
ClinicalTrials.gov record NCT01606072
Completed at the retained observation.
Open cited registry record →2013
3 recordsLeuprolide · 2013-11-06
ClinicalTrials.gov record NCT00002580
Completed at the retained observation.
Open cited registry record →Leuprolide · 2013-08-02
ClinicalTrials.gov record NCT00002582
Completed at the retained observation.
Open cited registry record →Triptorelin · 2013-06-26
ClinicalTrials.gov record NCT00311636
Completed at the retained observation.
Open cited registry record →2012
1 recordGoserelin · 2012-09-06
ClinicalTrials.gov record NCT00605267
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.